Clinical trials
Type 2 diabetes clinical trials
A condition where the body can’t use insulin properly, raising blood sugar. We’re tracking 1,078 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07518004Recruiting
ROME GS System Study for diabetes glucose monitoring
This study tests the ROME GS System, a glucose monitoring device that measures blood sugar levels. The system includes a sensor placed under the skin and a transmitter worn on the body. If you have diabetes and want to help evaluate a new way to track your blood sugar, this trial may be for you.
Escondido, CaliforniaAges 18 years+ - NCT07524205Recruiting
Activity and glucose tracking to reduce sitting in older adults with type 2 diabetes
This study helps older adults with type 2 diabetes understand how their blood sugar and daily activity are connected. You'll wear devices that track your glucose (blood sugar) and movement, and the research team will use this information to help you sit less and move more.
Minneapolis, MinnesotaAges 55 years+ - NCT07531459Recruiting
Understanding Health Behaviors in Type 2 Diabetes
This study is creating and testing a new tool to measure healthy behaviors in people with type 2 diabetes. Researchers want to understand how patients manage their diabetes day-to-day and how healthcare workers can better support them.
Changzhou, JiangsuAges 18 years+ - NCT07533175RecruitingPhase 3
Testing a new weight-loss medicine for type 2 diabetes
This study tests whether a new medicine called NNC0487-0111 helps people with type 2 diabetes and excess weight lose weight. You'll take the medicine along with your current diabetes care to see if it works better than standard treatment.
Birmingham, AlabamaAges 18 years+ - NCT07535307RecruitingPhase 1
Testing NNC0487-0111 to regulate insulin in type 2 diabetes
This early-stage study tests a new experimental drug (NNC0487-0111) designed to help regulate insulin levels in adults with type 2 diabetes. Researchers want to see if it works safely and effectively when combined with your current diabetes medications.
NeussAges 18–75 - NCT07546929RecruitingPhase 2
HP-211 Safety Study for Type 2 Diabetes Treatment
This study tests a new medicine called HP-211 in people with early-stage type 2 diabetes to see if it's safe and helps control blood sugar. You'd take the study drug along with your current diabetes management.
Canoga Park, CaliforniaAges 18 years+ - NCT07552389RecruitingPhase 3
Blood Pressure and Diabetes Combination Drug Trial
This study tests whether taking two separate blood pressure medications work as well as taking them combined in one pill for people with high blood pressure and type 2 diabetes. The goal is to find the best, safest way to treat both conditions together.
SeoulAges 19 years+ - NCT07554443Recruiting
Wearable Device to Improve Balance and Walking in Older Adults
This study tests a wearable device called Walkasins that uses gentle vibrations on your foot to help improve balance and walking ability. It's designed for older adults with nerve damage in their feet who have difficulty with balance.
Jacksonville, FloridaAges 60 years+ - NCT07556497Recruiting
Blood cells and inflammation in diabetic heart disease
This study looks at why people with type 2 diabetes develop heart problems. Researchers will examine special cells in your blood and inflammation markers to better understand these complications.
DohaAges 18 years+ - NCT07558863RecruitingPhase 4
GLP-1 medication's effect on nerve damage in type 2 diabetes
This study tests whether a GLP-1 medication (a type of diabetes drug) can help protect nerves in the heart from damage caused by diabetes. If you have type 2 diabetes and are overweight, this trial might help researchers understand if this medication improves how your heart's nervous system works.
Nanjing, JiangsuAges 18–70 - NCT07564414RecruitingPhase 3
Weight Loss Study Comparing Two Doses of CagriSema
This study tests whether a new combination medication called CagriSema (in two different doses) helps people with obesity lose weight. You may qualify if you're 18 or older, have a BMI of 35 or higher, and either don't have type 2 diabetes or have it well-controlled.
Birmingham, AlabamaAges 18 years+ - NCT07568678RecruitingPhase 1
Testing HMS1005 in adults with type 2 diabetes
This study tests a new medicine called HMS1005 in people with type 2 diabetes. Researchers want to see how safe it is and how the body responds to different doses. You may qualify if you have type 2 diabetes that is either untreated or controlled with common diabetes medications.
Miami, FloridaAges 18–65 - NCT07573917Recruiting
Cold Shivering to Improve Insulin Sensitivity in Type 2 Diabetes
This study tests whether controlled exposure to cold—which causes your body to shiver and produce heat—can help your body use insulin better. You'll undergo repeated cold sessions over several weeks while researchers monitor your blood sugar control and metabolism.
Sherbrooke, QuebecAges 40–75 - NCT07574138Recruiting
How Beta Cells Work in Early-Onset Type 2 Diabetes
This study examines how insulin-producing cells (beta cells) function in people diagnosed with type 2 diabetes before age 40. Understanding these differences may help doctors develop better treatments for younger patients.
Ho Chi Minh City, Cho Lon WardAges Any age - NCT07574333Recruiting
Breathing Training to Help Type 2 Diabetes Management
This study tests whether special breathing exercises that alternate between low and high oxygen levels can help people with type 2 diabetes manage their condition better. Researchers want to see if short or longer courses of this training improve blood sugar control and overall health.
MoscowAges 50–74 - NCT07581145RecruitingPhase 3
Semaglutide for Faster Healing of Diabetic Foot Ulcers
This study tests whether a diabetes medication called semaglutide can help foot ulcers heal faster in people with type 2 diabetes. If it works, it could offer a new treatment option for a common and serious diabetes complication.
CopenhagenAges 18–90 - NCT07583355Recruiting
Team-Based Counseling to Help Diabetes and Activity
This study tests whether meeting with a team of healthcare providers helps people with type 2 diabetes become more physically active and manage their condition better. You'll receive personalized guidance on exercise and diabetes care.
Perugia, PGAges 25–80 - NCT07591103Recruiting
Understanding Diabetes Self-Care and Health Literacy
This research study examines how social factors, education, and personal beliefs affect how well people with diabetes manage their condition on their own. The goal is to understand what helps patients take better care of their diabetes day-to-day.
Alexandria, Alexandria GovernorateAges 18 years+ - NCT07602023Recruiting
Fat Response and Diabetes Risk Study
This study looks at how your body processes fat after eating and measures certain blood markers to understand who might develop diabetes or complications. You'll eat a high-fat meal and have blood drawn to help doctors identify early warning signs.
Ferrara, FerraraAges 50–70 - NCT07605572Recruiting
GLP-1 drugs and dry eye disease in type 2 diabetes
This study tests whether a diabetes and weight-loss medication called GLP-1 receptor agonists affects dry eye disease. Researchers want to see if this medication helps or worsens dry eyes in people with type 2 diabetes and obesity.
AthensAges 18 years+ - NCT07614230RecruitingPhase 4
SGLT2 drugs and heart artery health in diabetes
This study tests whether a diabetes medication called SGLT2 inhibitors can slow the buildup of plaque in heart arteries. Researchers will use special CT scans to track changes in your coronary arteries over time.
Beijing, Beijing MunicipalityAges 18–78 - NCT07619157RecruitingPhase 1
ONO-3310 Study for Kidney Disease and Type 2 Diabetes
This early-stage trial tests a new drug called ONO-3310 in two groups: healthy adults and people with kidney disease caused by type 2 diabetes. The study aims to understand how the drug works and whether it might help protect kidney function in people with diabetes.
Fukuoka, FukuokaAges 18–64 - NCT07638345Recruiting
AI-powered weight management for teens with diabetes or asthma
This study tests a smartphone app that uses artificial intelligence to help families manage weight and health for teenagers (ages 12–21) with Type 1 Diabetes or asthma. The app is designed to be personalized to each family's needs and may help improve overall health outcomes.
SevilleAges 18 years+ - NCT07641361Recruiting
Staying Hydrated to Feel Better on GLP-1 Medication
This study tests whether drinking more water helps reduce uncomfortable side effects (like nausea and vomiting) when you first start taking GLP-1 medications for weight loss or diabetes. You'll be asked to follow a hydration plan and report how you feel.
Buffalo, New YorkAges 18–60
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for type 2 diabetes?
- Yes. Clin2 currently lists 1,078 recruiting type 2 diabetes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a type 2 diabetes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a type 2 diabetes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.